Current management guidelines – such as those produced by the National Institute of Health and Clinical Excellence (NICE)1 and the Global Initiative for Chronic Obstructive Lung Disease (GOLD)2 – emphasise the need for regular and effective patient monitoring and assessment. The CAT has been developed in line with the goals of these guidelines, with the aim of making these tasks easier and less time-consuming.
GSK does not recommend, endorse or accept liability for sites controlled by third-parties.
Page Last Updated: April 25, 2012
COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.
